Dilazep
Dilazep is a vasodilator that acts as an adenosine reuptake inhibitor.[1]
 | |
| Clinical data | |
|---|---|
| Trade names | Comelian Kowa |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
IUPAC name
| |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C31H44N2O10 |
| Molar mass | 604.69 g/mol g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
It is used for the treatment of cardiopathy and renal disorders.[2]
See also
- Hexobendine, a drug with similar chemical structure
References
- Hiroshi Deguchi; Hiroyuki Takeya; Hideo Wada; Esteban C. Gabazza; Nobuyuki Hayashi; Hajime Urano; Koji Suzuki (September 15, 1997). "Dilazep, an Antiplatelet Agent, Inhibits Tissue Factor Expression in Endothelial Cells and Monocytes". Blood. 90: 2345–2356.
- kowa pharmaceuticals
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.